Incyte Corp. (INCY)
127.75
-0.37
(-0.29%)
USD |
NASDAQ |
Aug 27, 16:00
127.62
-0.13
(-0.10%)
After-Hours: 18:18
Incyte EPS Diluted (TTM) : 7.846 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.846 |
| March 31, 2026 | 7.072 |
| December 31, 2025 | 6.403 |
| September 30, 2025 | 5.961 |
| June 30, 2025 | 4.399 |
| March 31, 2025 | 0.3232 |
| December 31, 2024 | 0.2712 |
| September 30, 2024 | 0.1412 |
| June 30, 2024 | 0.3549 |
| March 31, 2024 | 3.295 |
| December 31, 2023 | 2.645 |
| September 30, 2023 | 1.882 |
| June 30, 2023 | 1.628 |
| March 31, 2023 | 1.448 |
| December 31, 2022 | 1.522 |
| September 30, 2022 | 3.935 |
| June 30, 2022 | 4.250 |
| March 31, 2022 | 4.201 |
| December 31, 2021 | 4.272 |
| September 30, 2021 | 2.409 |
| June 30, 2021 | 1.522 |
| March 31, 2021 | 2.166 |
| December 31, 2020 | -1.400 |
| September 30, 2020 | -1.570 |
| June 30, 2020 | -0.9114 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.744 |
| December 31, 2019 | 2.051 |
| September 30, 2019 | 1.863 |
| June 30, 2019 | 1.414 |
| March 31, 2019 | 1.17 |
| December 31, 2018 | 0.51 |
| September 30, 2018 | -0.5187 |
| June 30, 2018 | -0.4887 |
| March 31, 2018 | -0.7887 |
| December 31, 2017 | -1.559 |
| September 30, 2017 | -0.80 |
| June 30, 2017 | -0.78 |
| March 31, 2017 | -0.54 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 0.78 |
| June 30, 2016 | 0.37 |
| March 31, 2016 | 0.24 |
| December 31, 2015 | 0.01 |
| September 30, 2015 | -0.50 |
| June 30, 2015 | 0.05 |
| March 31, 2015 | -0.22 |
| December 31, 2014 | -0.32 |
| September 30, 2014 | -0.36 |
| June 30, 2014 | -0.83 |
| March 31, 2014 | -0.63 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | -14.55 |
| Regeneron Pharmaceuticals, Inc. | 40.46 |
| BioMarin Pharmaceutical, Inc. | 0.3709 |
| Eli Lilly & Co. | 29.43 |
| Biogen, Inc. | 5.647 |